Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer
Nikki Burdett, Madelynne O. Willis, Kathryn Alsop, Allison L. Hunt, Ahwan Pandey, Phineas T. Hamilton, Tamara Abulez, Xuan Liu, Therese Hoang, Stuart Craig, Sián Fereday, Joy Hendley, Dale W. Garsed, Katy Milne, Shreena Kalaria, Ashley Marshall, Brian L. Hood, Katlin N. Wilson, Kelly A. Conrads, Kathleen I. Pishas, Sumitra Ananda, Clare L. Scott, Yoland Antill, Orla McNally, Linda Mileshkin, Anne Hamilton, George Au‐Yeung, Lisa Devereux, Heather Thorne, Andrea H. Bild, Nicholas W. Bateman, G. Larry Maxwell, Jeffrey T. Chang, Thomas P. Conrads, Brad H. Nelson, David D.L. Bowtell, Elizabeth L. Christie
Topics & Concepts
BiologySerous ovarian cancerHomologous recombinationSerous fluidOvarian cancerHomologous chromosomeRecombinationGeneticsCancer researchCancerGeneBiochemistryDNA Repair MechanismsPARP inhibition in cancer therapyCRISPR and Genetic Engineering